|
PLS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07371922253697E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62909996603844E-09 |
| Normal-vs-Stage2 |
8.457000E-03 |
| Normal-vs-Stage3 |
7.121600E-02 |
| Normal-vs-Stage4 |
7.798600E-01 |
| Stage1-vs-Stage2 |
8.860800E-01 |
| Stage1-vs-Stage3 |
1.195210E-01 |
| Stage1-vs-Stage4 |
1.787730E-04 |
| Stage2-vs-Stage3 |
1.818020E-01 |
| Stage2-vs-Stage4 |
1.610240E-02 |
| Stage3-vs-Stage4 |
1.522990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.04600789036158E-12 |
| Normal-vs-AfricanAmerican |
2.04569999995297E-06 |
| Normal-vs-Asian |
8.211000E-01 |
| Caucasian-vs-AfricanAmerican |
1.459580E-01 |
| Caucasian-vs-Asian |
7.335700E-03 |
| AfricanAmerican-vs-Asian |
7.152200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.31636973227978E-13 |
| Normal-vs-Female |
4.82239999999301E-06 |
| Male-vs-Female |
6.183400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.617700E-03 |
| Normal-vs-Extreme_Weight |
2.23560000001122E-06 |
| Normal-vs-Obese |
2.43409999999278E-05 |
| Normal-vs-Extreme_Obese |
6.306400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.739600E-01 |
| Normal_Weight-vs-Obese |
1.860780E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.968020E-01 |
| Extreme_Weight-vs-Obese |
7.032600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.018400E-01 |
| Obese-vs-Extreme_Obese |
6.663200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.737800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.21880333287572E-11 |
| Normal-vs-Age(61-80Yrs) |
1.3182000002665E-07 |
| Normal-vs-Age(81-100Yrs) |
6.622500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.088600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.106600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.382400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.944420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.535600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.027600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
2.597500E-03 |
| Normal-VS-KIRP CIMP |
6.148200E-01 |
| Normal-VS-Unclassified PRCC |
8.994400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.380500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.59779999967469E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.759600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.538500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.317240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.017020E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.202900E-03 |
| Normal-vs-N1 |
9.442500E-02 |
| Normal-vs-N2 |
9.981600E-01 |
| N0-vs-N1 |
4.304600E-01 |
| N0-vs-N2 |
3.394200E-01 |
| N1-vs-N2 |
4.727600E-01 |
|
|
